Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1609577618
Since 2023
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5718 2nd Ave
Brooklyn, NY, 11220
Phone (646) 754-8531
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.2M
629 prescriptions
Company payments, 2025
$1,009
From 15 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kina Y Chan prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 103 prescriptions and refills. In total Kina Y Chan wrote 629 Medicare prescriptions that cost $3.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tagrisso Osimertinib Mesylate | 103 | 104 | 17 | $1.7M |
| Dexamethasone Sodium Phosphate Generic | 33 | 33 | 13 | $127 |
| Hydroxyurea Generic | 31 | 43 | Under 11 | $630 |
| Procrit Epoetin Alfa | 28 | 28 | 16 | $116K |
| Opdivo Nivolumab | 27 | 27 | Under 11 | $206K |
| Prednisone Generic | 22 | 22 | Under 11 | $59.71 |
| Anastrozole Generic | 21 | 35 | Under 11 | $138 |
| Keytruda Pembrolizumab | 20 | 20 | Under 11 | $191K |
| Retacrit Epoetin Alfa-Epbx | 17 | 17 | Under 11 | $30K |
| Nivestym Filgrastim-Aafi | 14 | 14 | Under 11 | $29K |
| Palonosetron Hcl Generic | 14 | 14 | Under 11 | $2,764 |
| Pemetrexed Disodium Generic | 13 | 13 | Under 11 | $33K |
| Truxima Rituximab-Abbs | 12 | 12 | Under 11 | $74K |
| Abiraterone Acetate Generic | 12 | 12 | Under 11 | $11K |
| Dexamethasone Generic | 11 | 11 | Under 11 | $186 |
Brand drugs: 326 claims; generic drugs: 303 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kina Y Chan $1,009 ($1,009 in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 5 | $191 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $183 |
| Merck Sharp & Dohme LLC MRK | 2 | $150 |
| Lilly USA, LLC LLY | 1 | $120 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $73.22 |
| Daiichi Sankyo Inc. 4568.T | 2 | $41.92 |
| Puma Biotechnology, Inc. PBYI | 2 | $34.2 |
| Recordati_rare_diseases_inc. | 1 | $34.2 |
| Ge Healthcare GEHC | 1 | $31.24 |
| BeOne Medicines USA, Inc. ONC | 1 | $30 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.